La-Urshalar Brock, FNP-BC, CNM, describes tactics for managing dermatologic AEs in patients with breast cancer as part of a ...
Patient education conversations emphasize 3 core elements: equivalent efficacy supported by rigorous pharmacokinetic and ...
Dermatitis and lymphedema are among the most pertinent adverse effects of radiation to the breast, according to Alexa M. Lantz, MSPAS, PA-C.
Kevin Y. Chen, PharmD, MS, BCOP, CPP, discusses how next-generation sequencing improves biomarker testing and treatment ...
A patient with breast cancer was able to avoid unnecessary mastectomy through the use of a virtual reality simulation, ...
Kelly Preti, DNP, MBA, AGACNP-BC, OCN, PMGT-BC, is an adult-gerontology acute care nurse practitioner and APP education specialist within Memorial Sloan Kettering Cancer Center’s anesthesia pain ...
BCMA-targeting ADC belantamab mafodotin was approved for use in patients with relapsed/refractory multiple myeloma after 2 or more lines of treatment. Belantamab mafodotin-blmf (Blenrep) has been ...
Frontline lenvatinib, pembrolizumab, and chemotherapy did not lead to increased overall survival vs chemoimmunotherapy in patients with advanced ESCC. The addition of lenvatinib (Lenvima) to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback